+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

France Diabetes Market Report: 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • July 2024
  • Region: France
  • IMARC Group
  • ID: 5985319
Description Jump to:
The France diabetes market size reached US$ 1.10 billion in 2023. Looking forward, the publisher expects the market to reach US$ 1.78 billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2023-2032.

This new report “France Diabetes Market Report: 2024-2032” provides an analytical and statistical insight into the France diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in France. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the France diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the France diabetes market in any form.

What this Report Achieves:

Comprehensive situation analysis of the France diabetes epidemiology and its dynamics:

Focus of the Analysis:

Historical, current and future prevalence of diabetes in France
Historical, current and future prevalence of type-1 and type-2 diabetes in France
Historical, current and future prevalence of diabetes in the urban and rural regions in France
Historical, current and future prevalence of diabetes among males and females in France
Historical, current and future prevalence of diabetes among various age groups in France
Historical, current and future diagnosis rates for diabetes in France
Historical, current and future drug treatment rates for diabetes in France

Comprehensive situation analysis of the France Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

Performance of the Oral Antidiabetics market in France
Performance of key classes
Performance of key players
Market outlook

Comprehensive situation analysis of the France Insulin market and its dynamics:

Focus of the Analysis:

Performance of the Insulin market in France
Performance of key classes
Performance of key players
Market outlook

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 France Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 France Diabetes Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Forecast
7.5 SWOT Analysis
7.5.1 Overview
7.5.2 Strengths
7.5.3 Weaknesses
7.5.5 Opportunities
7.5.6 Threats
7.6 Value Chain Analysis
7.7 Porter’s Five Forces Analysis
7.7.1 Overview
7.7.2 Bargaining Power of Buyers
7.7.3 Bargaining Power of Suppliers
7.7.4 Degree of Competition
7.7.5 Threat of New Entrants
7.7.6 Threat of Substitutes
7.8 Market Breakup by Segment
7.8.1 France Oral Antidiabetics Market
7.8.1.1 Historical Market Trends
7.8.1.2 Market Breakup by Class
7.8.1.3 Market Shares of Key Players
7.8.1.4 Market Forecast
7.8.2 France Insulin Market
7.8.2.1 Historical Market Trends
7.8.2.2 Market Breakup by Class
7.8.2.3 Market Shares of Key Players
7.8.2.4 Market Forecast
8 Competitive Landscape
8.1 Competitive Structure
8.2 Profiles of Key Players
List of Figures
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2023 & 2032
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: France: Total Number of Diabetes Patients (in 000), 2018-2023
Figure 6: France: Total Number of Diabetes Patients Forecast (in 000), 2024-2032
Figure 7: France (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 8: France (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
Figure 9: France (Urban & Rural): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 10: France (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
Figure 11: France (Male & Female): Total Number of Diabetes Patients (in 000), 2018-2023
Figure 12: France (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
Figure 13: France: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in 000), 2018-2023
Figure 14: France: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, in 000), 2024-2032
Figure 15: France: Diabetes Drug Industry Overview
Figure 16: France: Diabetes Drug Market: Sales Value (in Million US$), 2018-2023
Figure 17: France: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: France: Diabetes Drug Market: SWOT Analysis
Figure 19: France: Diabetes Drug Market: Value Chain Analysis
Figure 20: France: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: France: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2018-2023
Figure 22: France: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2024-2032
Figure 23: France: Oral Antidiabetics Market: Sales Value (in Million US$), 2018-2023
Figure 24: France: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2018 & 2023
Figure 25: France: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: France: Oral Antidiabetics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: France: Insulin Market: Sales Value (in Million US$), 2018-2023
Figure 28: France: Breakup of Insulin Market by Class (in %), 2018 & 2023
Figure 29: France: Insulin Market: Sales Share of Key Players (in %)
Figure 30: France: Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
List of Tables
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2023 and 2032
Table 3: France: Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
Table 4: France (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
Table 5: France (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
Table 6: France (Male & Female): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
Table 7: France: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in 000), 2018, 2023 & 2032
Table 8: France: Diabetes Drug Market: Competitive Structure

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages140
PublishedJuly 2024
Forecast Period2023 - 2032
Estimated Market Value ( USD ) in 2023 $ 1100.9 Million
Forecasted Market Value ( USD ) by 2032 $ 1782.3 Million
Compound Annual Growth Rate5.5%
Regions CoveredFrance

Related Topics

Related Reports

Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, Demographic, Indication, End User, and Region 2024-2032 - Product Image

Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, Demographic, Indication, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Russia Diabetes Market Report: 2024-2032 - Product Image

Russia Diabetes Market Report: 2024-2032

  • Report
  • 133 Pages
  • Russia
From
Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Type (Type 1, Type 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Type (Type 1, Type 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 100 Pages
  • Global
From
Antidiabetics Market Report 2024 - Product Image

Antidiabetics Market Report 2024

  • Report
  • 175 Pages
  • Global
From
France Human Insulin Market, By Region, Competition, Forecast & Opportunities, 2019-2029F - Product Image

France Human Insulin Market, By Region, Competition, Forecast & Opportunities, 2019-2029F

  • Report
  • 80 Pages
  • France
From

About the Antidiabetic Market

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides. Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.